πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12138233

Methods of treating idiopathic hypersomnia

Jazz Pharmaceuticals Ireland Limited Β· Granted Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12138243

Antiviral use of FABP4 modulating compounds

CRESCENTA BIOSCIENCES Β· Granted Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12138301

Compounds including a mutant KRAS sequence and a lipid and uses thereof

Elicio Therapeutics, Inc. Β· Granted Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12133914

Hydrocortisone oral liquid formulations

Eton Pharmaceuticals, Inc. Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12133853

Pyruvate kinase activators for use in treating blood disorders

Agios Pharmaceuticals, Inc. Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12133924

Compositions and methods for organ specific delivery of nucleic acids

The Board of Regents of the University of Texas System Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12134642

Antibodies binding to Ξ±7Ξ²1 integrin antibodies and compositions thereof

Pliant Therapeutics, Inc. Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12133849

Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha- emitting

Actinium Phamaceuticals, Inc. Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12134650

Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12133840

Halogenated xanthene composition and method for treating hematologic cancers

Provectus Pharmatech, Inc. Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12133856

Multi-substituent psilocybin derivatives and methods of using

Enveric Biosciences Canada Inc. Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12133890

Antigen-binding polypeptide targeting B7H3 and application thereof

NINGBO T-MAXIMUM BIOPHARMACEUTICALS CO., LTD. Β· Granted Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12129288

Polynucleotides heterodimers of soluble interferon receptors and uses thereof

Sanabio, LLC Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128122

Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic

Krystal Biotech, Inc. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12129258

Diaryl macrocyclic compound and pharmaceutical composition, and use thereof

PrimeGene (Beijing) Co., Ltd. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12129467

Non-liposomal systems for nucleic acid delivery

ARBUTUS BIOPHARMA CORPORATION Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128048

Combination therapies using PRMT5 inhibitors for the treatment of cancer

Mirati Therapeutics, Inc. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128092

Lyophilized factor IX formulations

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128102

Constrained conditionally activated binding proteins

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128109

Muscle targeting complexes and formulations for treating dystrophinopathies

Dyne Therapeutics, Inc. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128034

Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof

Iterum Therapeutics International Limited Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128036

Compositions and methods for storage stable ophthalmic drugs

LENZ THERAPEUTICS OPERATIONS, INC. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128014

Use of thiol compounds to treat neurological disease

MERCAPTOR DISCOVERIES, INC. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128033

Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclo

Neurocrine Biosciences, Inc. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted